Date: Thursday, December 11th, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TITLE: New! Real-World Evidence to Support Optimization of Factor IX Prophylaxis SUMMARY: This webinar will discuss recent evidence on prophylactic treatment strategies for hemophilia B from a U.S. real-world retrospective analysis of factor IX products. The session will highlight factor Read the full article...

Date: Thursday, January 15th, 2026 Time: 1:00pm - 2:00pm ET         WEBINAR TITLE: Five-Year Analysis: Efficacy and Safety of HEMGENIX® SUMMARY: Presentation of the published efficacy and safety results of the five-year analysis of the HOPE-B clinical trial follow up. AUDIENCE: All HTC Staff. SPEAKER: Vidhi Desai, Senior Medical Director (Coagulation), US Read the full article...

Date: Tuesday, March 31st, 2026 Time: 1:00pm - 2:00pm ET         WEBINAR TOPIC: BrightStar Franchising, LLC Master Service Agreement for Nursing Services Now Available to Hemophilia Alliance Member Hemophilia Treatment Centers. OBJECTIVES: Understand the services of BrightStar Franchising, LLC. And what services are available to Hemophilia Alliance member HTCs under the Master Read the full article...

Date: Tuesday, April 28th, 2026 Time: 4:30pm - 5:30pm ET         WEBINAR TOPIC: Targeted Multi-Immune Modulation in ITP DESCRIPTION: This event will provide an overview of a multi-immune modulator that helps address the complex immune dysregulation in immune thrombocytopenia (ITP). The presentation will highlight key aspects of the disease pathophysiology, the potential Read the full article...

Date: Tuesday, May 12th, 2026 Time: 1:00pm - 2:00pm ET         WEBINAR TOPIC: Addressing Heavy Menstrual Bleeding in von Willebrand Disease: Clinical Insights and the Role of wilate® OBJECTIVES: Heavy menstrual bleeding (HMB) is one of the most common and underrecognized manifestations of von Willebrand disease (VWD) and represents a significant cause Read the full article...